Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19
Crossref DOI link: https://doi.org/10.1038/s41380-024-02635-0
Published Online: 2024-06-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zeng, Guangting
Li, Jianqiang
Wang, Linlin
Zhang, Zanling http://orcid.org/0000-0002-8707-0487
Text and Data Mining valid from 2024-06-21
Version of Record valid from 2024-06-21
Article History
Received: 20 March 2023
Revised: 17 June 2024
Accepted: 18 June 2024
First Online: 21 June 2024
Competing interests
: The authors declare no competing interests.